Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Phelps NH, Singleton RK, Zhou B, Al
Statements Author contributions YX and MW designed the manuscript
In pancreatic cancer, LAT2 ( SLC7A8 ) was shown to decrease gemcitabine sensitivity by regulating glutamine-dependent mTOR activation to promote proliferation and inhibit apoptosis (Feng et al., 2018)
In a multicentre, double-blind, placebo-controlled phase 2 study (NCT00672074 [15] ), 117 adults undergoing bowel resection were randomised to 0.03 mg/kg IV ipamorelin or placebo twice daily for up to 7 days
US$ 28.69
US$ 25.74
US$ 29.36
